References
Barbosa F Jr, Corrêa Rodrigues MH, Buzalaf MR, Krug FJ, Gerlach RF, Tanus-Santos JE (2006a) Evaluation of the use of salivary lead levels as a surrogate of blood lead or plasma lead levels in lead exposed subjects. Arch Toxicol 80:633–637
Barbosa F Jr, Sertorio JT, Gerlach RF, Tanus-Santos JE (2006b) Clinical evidence for lead-induced inhibition of nitric oxide formation. Arch Toxicol 80:811–816
Blaauboer BJ, Andersen ME (2007) The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative. Arch Toxicol 81:385–387
Bolt HM, Thier R (2006) Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 7:613–628
Creppy EE, Moukha S, Bacha H, Carratu MR (2005) How much should we involve genetic and environmental factors in the risk assessment of mycotoxins in humans? Int J Environ Res Public Health 2:186–193
Dewa Y, Nishimura J, Muguruma M, Matsumoto S, Takahashi M, Jin M, Mitsumori K (2007) Gene expression analyses of the liver in rats treated with oxfendazole. Arch Toxicol 81:647–654
Duydu Y, Süzen HS, Aydin A, Cander O, Uysal H, Isimir A, Vural N (2001) Correlation between lead exposure indicators and sister chromatid exchange (SCE) frequencies in lymphocytes from inorganic lead exposed workers. Arch Environ Contam Toxicol 41:241–246
Ellinger-Ziegelbauer H, Gmuender H, Bandenburg A, Ahr HJ (2008) Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutat Res 637:23–39
Godin M, Fillastre JP, Simon P, Francois A, Roy FL, Morin JP (1997) Is ochratoxin nephrotoxic in human beings? Adv Nephrol Necker Hosp 26:181–206
Greim H, Arand M, Autrup H, Bolt HM, Bridges J, Dybing E, Glomot R, Foa V, Schulte-Hermann R (2006) Toxicological comments to the discussion about REACH. Arch Toxicol 80:121–124
Hallier E, Langhof T, Dannappel D, Leutbecher M, Schröder K, Goergens HW, Müller A, Bolt HM (1993) Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol 67:173–178
Hallier E, Schröder KR, Asmuth K, Dommermuth A, Aust B, Goergens HW (1994) Metabolism of dichloromethane (methylene chloride) to formaldehyde in human erythrocytes: influence of polymorphism of glutathione transferase theta (GST T1–1). Arch Toxicol 68:423–427
Höfer T, Gerner I, Gundert-Remy U, Liebsch M, Schulte A, Spielmann H, Vogel R, Wettig K (2004) Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation. Arch Toxicol 78:549–564
Huang B, Tao W, Shi J, Tang L, Jin J (2006) Determination of ochratoxin A by polyclonal antibodies based sensitive time-resolved fluoroimmunoassay. Arch Toxicol 80:481–485
Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H (2008) Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 108(1):137–149
Kashida Y, Takahashi A, Moto M, Okamura M, Muguruma M, Jin M, Arai K, Mitsumori K (2006) Gene expression analysis in mice liver on hepatocarcinogenesis by flumequine. Arch Toxicol 80:533–539
Klaric MS, Rumora L, Ljubanovic D, Pepeljnjak S (2008) Cytotoxicity and apoptosis induced by fumonisin B1, beauvericin and ochratoxin A in porcine kidney PK15 cells: effects of individual and combined treatment. Arch Toxicol 82(4):247–255
Krstev S, Stewart P, Rusiecki J et al (2007) Mortality among shipyard coastguard workers: a retrospective cohort study. Occup Environ Med 64:651–658
Montenegro MF, Barbosa F Jr, Sandrim VC, Gerlach RF, Tanus-Santos JE (2006) A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio. Arch Toxicol 80:394–398
Nagashima H, Maeda-Nakamura K, Iwashita K, Goto T (2007) Induced secretion of insulin-like growth factor binding protein-1 (IGFBP-1) in human hepatoma cell HepG2 by rubratoxin B. Arch Toxicol 81:347–351
Nampoothiri LP, Agarwal A, Gupta S (2007) Effect of co-exposure to lead and cadmium on antioxidant status in rat ovarian granulose cells. Arch Toxicol 81:145–150
Pauwels M, Rogiers V (2007) EU legislations affecting safety data availability of cosmetic ingredients. Regul Toxicol Pharmacol 49:308–315
Raulf-Heimsoth M, Pesch B, Schott K, Kappler M, Preuss R, Marczynski B, Angerer J, Rihs HP, Hahn JU, Merget R, Brüning T (2007) Irritative effects of fumes and aerosols of bitumen on the airways: results of a cross-shift study. Arch Toxicol 81:35–44
Rezende VB, Barbosa F Jr, Montenegro MF, Sandrim VC, Gerlach RF, Tanus-Santos JE (2008) Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects. Arch Toxicol 82:29–36
Schrickx J, Lektarau Y, Fink-Gremmels J (2006) Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch Toxicol 80:243–249
Schwender H, Ickstadt K (2008) Identification of SNP interactions using logic regression. Biostatistics 9:187–198
Shen J, Lin G, Yuan W, Tan J, Bolt HM, Thier R (1998) Glutathione transferase T1 and M1 genotype polymorphism in the normal population of Shanghai. Arch Toxicol 72:456–458
Sul D, Kim H, Oh E, Phark S, Cho E, Choi S, Kang HS, Kim EM, Hwang KW, Jung WW (2007) Gene expression profiling in lung tissues from rats exposed to formaldehyde. Arch Toxicol 81:589–597
Tomita M, Okuyama T, Katsuyama H, Ishikawa T (2006) Paraquat-induced gene expression in rat kidney. Arch Toxicol 80:687–693
Author information
Authors and Affiliations
Corresponding author
Additional information
Compiled on behalf of the EUROTOX Speciality Section Carcinogenesis.
Rights and permissions
About this article
Cite this article
Degen, G.H., Hengstler, J.G. Developments in industrial and occupational toxicology: REACH, toxicogenomics, mycotoxins, lead, asbestos, boron, bitumen, deletions polymorphisms and SNP interactions. Arch Toxicol 82, 483–487 (2008). https://doi.org/10.1007/s00204-008-0315-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-008-0315-9